Stock ATXS ASTRIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Astria Therapeutics, Inc.

Equities

ATXS

US04635X1028

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
9.54 USD +1.17% Intraday chart for Astria Therapeutics, Inc. -1.95% +24.22%
May. 09 Astria Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 23 HC Wainwright Cuts Astria Therapeutics' Price Target to $16 From $18, Maintains Buy Rating MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
BU
Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Astria Therapeutics : - 2024 Proxy Statement
PU
Astria Therapeutics : - 2023 Annual Report
PU
Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors
BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Astria Therapeutics : Material Event - Form 8-K
PU
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
BU
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology Annual Meeting
AQ
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting
BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference
BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
BU
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATXS Stock
  4. News Astria Therapeutics, Inc.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW